MENU
IMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
I-MAB (IMAB) Ownership - Who owns I-MAB?
I-MAB is a clinical-stage biotech company... Show more
Profile
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
333.99M
P/E Ratio
N/A
Total Cash
165.61M
Projected Growth
N/A
Total Debt
3.48M
Revenue
N/A
Risk (Beta)
2.52
Dividend Yield
N/A
Total Cash/Share
2.03
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMAB
Capitalization
334M
P/E Ratio
N/A
Risk (Beta)
2.52
Dividend Yield
N/A
Total Cash
166M
Total Cash/Share
2.03
Total Debt
3.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
197M
P/B Ratio
1.70
Cash Flow
N/A
Earnings
-0.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
22.82
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-36.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.37
Shares Held By Institutions
20.4M
Shares Outstanding - Current
81.7M
Total Liabilities
9.98M
Total Volume MTD
N/A
Value
N/A
Gain YTD
381.176
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMAB showed earnings on August 20, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com